C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
11/2002
11/26/2002	US6485704 Azo compound for type I pototherapy
11/26/2002	CA2086643C Oxepane isomers of rapamycin useful as immunosuppressive agents
11/21/2002	WO2002092734A1 Antioxidants and antioxidant boosters capable of producing hydroperoxyl radicals
11/21/2002	WO2002092604A1 1-oxa-3,9-diaza-spiro'5,5!undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor
11/21/2002	WO2002092603A1 Oxazolo-and furopyrimidines and their use in medicaments against tumors
11/21/2002	WO2002092595A1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
11/21/2002	WO2002092083A1 7,8-fused 4$i(h)-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2002	WO2002092065A2 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
11/21/2002	WO2002092010A2 Reverse-turn mimetics and methods relating thereto
11/21/2002	WO2002062290A3 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
11/21/2002	US20020173521 Inhibitors of copper-containing amine oxidases
11/21/2002	US20020173503 Substituted pyridoindoles as serotonin agonists and antagonists
11/21/2002	US20020173474 Methods & materials involving dimerization-mediated regulation of biological events
11/21/2002	US20020173424 Heterocyclyl-substituted benzoylcyclohexandiones, their preparation, and their use as herbicides
11/21/2002	CA2449188A1 Oxazolo-and furopyrimidines and their use in medicaments against tumors
11/20/2002	EP1258255A1 Conjugates of an antibody to CD44 and a maytansinoid
11/20/2002	EP0892780B1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
11/20/2002	EP0833828B1 Rapamycin derivatives
11/19/2002	US6482845 Method for inhibiting interleukin-2 production using tricyclo compounds
11/19/2002	CA2063580C Receptor assay for fk-506
11/14/2002	WO2002090593A1 Screening for enzyme inhibitors
11/14/2002	WO2002090362A1 Azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene as 5-ht1a antagonists
11/14/2002	WO2002090355A1 N-aroyl cyclic amines
11/14/2002	WO2002089858A1 Azo compounds for type i phototherapy
11/14/2002	WO2002089806A1 Heterobicycles fkbp-ligands
11/14/2002	US20020169317 Oxazinocarbazoles for the treatment of CNS diseases
11/14/2002	US20020169200 Antitumor, antiinflammatory and antiarthritic agents, treating metastasis, restenosis, osteoporosis, inflammation, macular degeneration, and diabetic retinopathy
11/14/2002	US20020169153 Substituted aromatic compounds for treatment of antibiotic resistant infections
11/14/2002	US20020169111 Reversal of multidrug resistance in human colon carcinoma cells
11/14/2002	CA2446795A1 Sulfamide, sulfamate, sulfonamide, urea, amide, alpha, alpha-difluoro amide oxalyl diamide, and heterobicycles fkbp-binding ligands
11/14/2002	CA2446396A1 N-aroyl cyclic amines
11/13/2002	EP1256576A1 Fused imidazolium derivatives
11/13/2002	EP1255759A1 Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds
11/13/2002	EP1255758A1 Apoptosis-inducing compounds
11/13/2002	EP1255739A1 3-aminoquinazolin-2,4-dione antibacterial agents
11/13/2002	EP1255738A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
11/13/2002	EP0650489B1 Rapamycin derivatives
11/13/2002	CN1379779A Process for preparation of benzoxazine derivatives and intermediates therefor
11/12/2002	CA2099591C 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3- carboxylic acid compounds useful as antibacterial agents
11/12/2002	CA2018564C 4,5,5a,6-tetrahydro-3h-isoxazolo¬5,4,3-kl\|acridines derivatives, a process for their preparation and their use as medicaments
11/07/2002	WO2002088142A1 ANTIPSYCHOTIC AMINOMETHYL DERIVATIVES OF 7,8-DIHYDRO-3H-1,6,9-TRIOXA-3-AZA-CYCLOPENTA[a]NAPHTHALEN-2-ONE
11/07/2002	WO2002088141A2 ANTIPSYCHOTIC AMINOMETHYL DERIVATIVES OF 7,8-DIHYDRO-2,6,9-TRIOXA-3-AZA-CYCLOPENTA[a]NAPHTHALENE
11/07/2002	WO2002088140A1 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene
11/07/2002	WO2002088139A1 6h-oxazolo[4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
11/07/2002	WO2002088135A1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-[1,4]-benzodioxans
11/07/2002	WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002	WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002	WO2002088080A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002088079A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002087513A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/07/2002	WO2002050084A3 Streptogramin derivatives preparation thereof and compositions containing same
11/07/2002	US20020165250 Materials and method for treating or preventing pathogenic fungal infection
11/07/2002	US20020164287 Azo compounds for type i phototherapy
11/07/2002	CA2445859A1 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene
11/07/2002	CA2445543A1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-¬1,4\|-benzodioxans
11/07/2002	CA2444436A1 Dual inhibitors of pde 7 and pde 4
11/07/2002	CA2443835A1 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/06/2002	EP1254116A1 Alpha v integrin receptor antagonists
11/06/2002	EP1254115A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
11/06/2002	EP1157024B1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/06/2002	CN1378548A Method for separating analogous organic compounds
11/06/2002	CN1378542A FAB I inhibitors
11/06/2002	CN1093767C Protein kinase C inhibitors
11/06/2002	CN1093759C 蛋白激酶c抑制剂 Protein kinase c inhibitor
11/05/2002	US6476036 Sodium salt of 3-(4-cinnamyl-1-piperazinyl)-imino-methyl rifamycin SV
11/05/2002	US6476021 Compounds having cGMP-PDE inhibitory effect
11/05/2002	US6476018 Fused imidazole derivatives as multidrug resistance modulators
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002086160A1 Hybridization probes
10/31/2002	WO2002086143A2 Enzymatic process for preparing cephalosporin derivatives
10/31/2002	WO2002085914A2 ENZYMATIC PROCESS FOR PREPARING CEPHALOSPORANIC ACID DERIVATIVES USING α-KETOACID DERIVATIVES
10/31/2002	WO2002085869A1 Arylsulfonamides as antiviral agents
10/31/2002	WO2002085860A1 Pyrazole derivatives for treating hiv
10/31/2002	WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002	WO2002085850A1 Cyclic amidine derivative
10/31/2002	WO2002085843A2 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/31/2002	WO2002085359A1 Agent for topical ophthalmic treatment of ocular inflammatory diseases
10/31/2002	WO2002064574A3 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
10/31/2002	US20020161029 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
10/31/2002	US20020161005 Nitrogen heterocycle compounds
10/31/2002	US20020160994 The beta-hydroxy lactone, such as -(+)-5-ethyl-9,10-difluoro-5-hydroxy-4,5,13,15-tetrahydro-1H,3H -oxepino(3',4':6,7)indolizino(1,2-b)quinoline-3,15-dione
10/31/2002	US20020160984 For example, 2,3-dihydro-1H-benz(de)isoquinolin-1-one; treating diabetes, cancer, radiosensitizing tumor cells, cardiovascular disorders, septic shock, inflammatory bowel disease, senescent cells
10/31/2002	DE10121217A1 6H-Oxazolo[4,5-e]indol-Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden 6H-oxazolo [4,5-e] indole derivatives as nicotinic acetylcholine receptor ligands and / or serotonergic ligands
10/31/2002	CA2445508A1 Agent for topical ophthalmic treatment of ocular inflammatory diseases
10/31/2002	CA2443946A1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/30/2002	EP1252165A1 Isoxazolo pyrimidinones and the use thereof
10/30/2002	EP1252163A2 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
10/30/2002	EP1252150A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
10/30/2002	CN1377358A Novel herbicides
10/29/2002	US6472419 1-H-3-aryl-pyrrolidine-2, 4-dione derivatives as pest-control agents
10/29/2002	US6472416 Sulfonylphenylpyrazole compounds useful as COX-2 inhibitors
10/24/2002	WO2002083691A1 New process for the preparation of oxabispidines
10/24/2002	WO2002083690A1 New process for the preparation of oxabispidines
10/24/2002	WO2002083689A1 3,7-diazabicyclo [3.3.1] formulations as anti-arrythmic compounds
10/24/2002	WO2002083688A1 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds
10/24/2002	WO2002083687A1 3,7-diazybicyclo [3.3.1] formulations as antiarrhytmic compounds
10/24/2002	WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002	WO2002066019A3 Cancer treatment
10/24/2002	WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002	WO2000040247A9 2-oxy-benzoxazinone derivatives for the treatment of obesity

1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 220